Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

The researchers reported that platelet-rich plasma treatment increased hair growth in androgenic alopecia patients, potentially by altering scalp microbiota composition, including increased Cutibacterium and decreased Staphylococcus and Lawsonella.

In this retrospective cohort study, 87.1% of pediatric patients with chemotherapy-induced alopecia experienced clinical improvement after treatment with minoxidil or combination therapy with CYP, with the combination therapy showing greater hair thickness and minimal adverse effects.

This review discusses the impact of dysbiosis on scalp diseases like seborrheic dermatitis and alopecia areata, reporting no new results; the authors suggest the microbiome could offer therapeutic options.

Female androgenetic alopecia affects many women, is reversible with treatment like Minoxidil, and has significant psychological impacts.

This study found that hydroxychloroquine was less effective than betamethasone oral mini pulse therapy in managing alopecia areata, with patients on hydroxychloroquine experiencing score increases and more relapses at 24 weeks, though adverse event rates were similar between the groups.

This study found that infrared thermography might be a useful non-invasive tool to help diagnose frontal fibrosing alopecia by identifying active phases of the disease.

This study observed that ECMs produced by papillary fibroblasts showed the largest fibers and supported keratinocyte differentiation better than reticular fibroblast matrices, informing biomimetic material design for skin tissue engineering.

This study observed that treating alopecia seborrhoeica with bushen shengfa formula and finasteride was more effective and improved associated symptoms better than using liuwei dihuang wan and finasteride.

Finasteride is not effective for older women with hair loss.

In this study, patients with systemic lupus erythematosus and generalized non-scarring alopecia exhibited hair loss similar to telogen effluvium, with significant changes observed in the cuticle of telogen hairs.

This article reviews several dermatology books, including those on dermatologic disorders in Black children and adolescents, but does not report any new research findings.

This study identified distinct myeloid subsets in the scalp of men with androgenetic alopecia, potentially revealing new drug targets for treatment.

This study identified four hub genes that are closely linked to the causative factors of androgenetic alopecia, suggesting potential diagnostic and therapeutic targets.

This study found that trichoscopy can confirm the diagnosis and assess the clinical severity of female androgenetic alopecia, correlating specific features with different severity grades.

This study explored the use of autologous PRP injections for androgenetic alopecia and found they were effective in increasing hair thickness and reducing hair loss, with more pronounced efficacy reported in women and a satisfactory safety profile.

This study found that PRP injections effectively reduced hair thinning and suggested greater efficacy in women with androgenetic alopecia.

This study suggests that using trichotillometry to establish the normal range of shear strain for different hair types could inform diagnostic and treatment decisions for various hair conditions.

This study found that in hair follicles, androgen receptor expression is stronger in the hair loss and transitional areas compared to the occipital region, suggesting a role in male pattern baldness.

In this study, researchers found that human scalp hair, particularly when unwashed, can significantly react with ozone, reducing personal ozone exposure and increasing exposure to volatile reaction products.

Pimecrolimus cream is not effective for treating alopecia areata.

This study suggests that transplanting hair to new nonscalp sites affects their growth and survival rates, though the hair diameter remains consistent.

This review discusses various methods to conceal hair loss, such as wigs and hair transplants, and reports no new clinical results; the authors evaluate each option's pros and cons.

This abstract discusses platelet-rich plasma therapy for patterned hair loss but provides no new clinical results, suggesting further research is needed to determine its effectiveness.

This study found that rosemary oil and minoxidil 2% both increased hair count equally in patients with androgenetic alopecia after 6 months, with more scalp itching seen in the minoxidil group.

This study found that trichoscopy has limited value for diagnosing telogen effluvium, as common findings are not specific enough to differentiate it from other conditions like androgenetic alopecia.

This study suggests that collecting hair samples from all scalp regions may be a viable alternative for measuring cortisol in individuals with Afro-textured or extremely short hair, aligning results with traditional methods.

This study found that multiple eccrine duct dilation is highly specific for diagnosing cicatricial alopecia and may indicate scarring processes, aiding in accurate differential diagnosis from noncicatricial alopecias.

This study found that platelet-rich plasma treatment was effective and safe for promoting hair regrowth in mild cases of alopecia areata, with significant improvements in quality of life compared to placebo.

In this randomized controlled study, the researchers found that an herbal extract combination showed similar efficacy to 3% minoxidil solution in treating androgenetic alopecia over 24 weeks, with no significant safety concerns, suggesting it might be a viable alternative treatment.

This study found that adding fexofenadine to DPCP treatment in non-atopic Alopecia areata patients did not significantly improve hair regrowth, but it did significantly reduce treatment-related discomfort.